PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 22, 2026Cancer Biology and Medicine0 citationsOpen Access

From overtreatment to precision: a new clinical standard for DCIS management

SSSchlomo Schneebaum

Key Points

  • The aim is to redefine management approaches for ductal carcinoma in situ, focusing on precision rather than overtreatment.
  • Conducted a literature review on DCIS diagnosis and treatment approaches.
  • Analyzed current clinical standards and their implications for patient outcomes.
  • Evaluated the biological characteristics of DCIS and its impact on treatment decisions.
  • Highlighted the non-invasive nature of DCIS and its limited metastatic potential.
  • Demonstrated that the labeling of DCIS as 'breast cancer' may lead to unnecessary overtreatment.
  • Suggested precision management strategies that could reduce patient anxiety and improve quality of care.

Abstract

Ductal carcinoma in situ (DCIS) remains one of the most conceptually challenging diagnoses in breast oncology. DCIS is technically non-invasive, contained within the basement membrane, and lacks metastatic potential in its pure form. Yet patients are told that they have “breast cancer,” a term

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Schlomo Schneebaum (2026) studied this question.

synapsesocial.com/papers/69bf8978f665edcd009e91a2https://doi.org/10.20892/j.issn.2095-3941.2026.0010
Ask AI
Helpful
Bookmark
Share
View Full Paper